[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2007202510A - Device for transpiring chemical - Google Patents

Device for transpiring chemical Download PDF

Info

Publication number
JP2007202510A
JP2007202510A JP2006027218A JP2006027218A JP2007202510A JP 2007202510 A JP2007202510 A JP 2007202510A JP 2006027218 A JP2006027218 A JP 2006027218A JP 2006027218 A JP2006027218 A JP 2006027218A JP 2007202510 A JP2007202510 A JP 2007202510A
Authority
JP
Japan
Prior art keywords
carrier
chemical
protective cover
heating element
space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006027218A
Other languages
Japanese (ja)
Other versions
JP5473185B2 (en
Inventor
Yasuyuki Hasegawa
靖之 長谷川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2006027218A priority Critical patent/JP5473185B2/en
Priority to PCT/JP2007/051952 priority patent/WO2007089019A1/en
Publication of JP2007202510A publication Critical patent/JP2007202510A/en
Application granted granted Critical
Publication of JP5473185B2 publication Critical patent/JP5473185B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01MCATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
    • A01M1/00Stationary means for catching or killing insects
    • A01M1/20Poisoning, narcotising, or burning insects
    • A01M1/2022Poisoning or narcotising insects by vaporising an insecticide
    • A01M1/2061Poisoning or narcotising insects by vaporising an insecticide using a heat source
    • A01M1/2077Poisoning or narcotising insects by vaporising an insecticide using a heat source using an electrical resistance as heat source
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • A61L9/03Apparatus therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Catching Or Destruction (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a device for transpiring chemicals which can enhance transpiration efficiency by suppressing formation of droplets of transpired chemicals. <P>SOLUTION: The device 1 for transpiring chemicals transpires the chemical by heating a support 14 in which the chemical is impregnated. The device 1 is equipped with a body 10 of the device having an exothermic body 12, a protection cover 20 attached to the body 10 of the device, a holding means 22 for holding the support 14 between the exothermic body 12 and the protection cover 20. The holding means 22 holds the support 14 in a raised state in a used condition and forms a space S between the support 14 and the protection cover 20 and the space S is formed to communicate at least the upper part with the out side. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、薬剤蒸散装置に関し、より詳しくは、薬剤を含浸させた担持体を加熱して薬剤を蒸散させる薬剤蒸散装置に関する。   The present invention relates to a chemical vaporization device, and more particularly to a chemical vaporization device that heats a carrier impregnated with a chemical to vaporize the chemical.

薬剤蒸散装置は、殺虫、殺菌、芳香、消臭など種々の目的のために従来から使用されている。薬剤蒸散装置の構成として、薬剤を含浸させた板状の担持体をヒータ等の発熱体により加熱することで、薬剤を蒸散させるものが知られている。   The chemical transpiration apparatus has been conventionally used for various purposes such as insecticide, sterilization, aroma, and deodorization. As a configuration of the chemical evaporation device, a plate-like carrier impregnated with the chemical is heated by a heating element such as a heater to evaporate the chemical.

例えば、特許文献1には、図8に示すように、薬剤を含有するマット状の薬剤含有体51が、装置本体52に設けられた発熱体53の上面に水平に配置され、これら薬剤含有体51及び発熱体53が半球状のカバー体54で覆われるように構成された薬剤加熱蒸散装置50が開示されている。カバー体54は、中央に蒸散孔55を有しており、発熱体53の加熱によって薬剤含有体51から蒸散した薬剤が、蒸散孔55を介して外部に放出される。
特開平7−322798号公報
For example, in Patent Document 1, as shown in FIG. 8, a mat-like drug-containing body 51 containing a drug is horizontally disposed on the upper surface of a heating element 53 provided in the apparatus main body 52, and these drug-containing bodies. A chemical heating transpiration apparatus 50 configured to cover 51 and a heating element 53 with a hemispherical cover body 54 is disclosed. The cover body 54 has a transpiration hole 55 at the center, and the medicine evaporated from the medicine-containing body 51 by the heating of the heating element 53 is discharged to the outside through the transpiration hole 55.
JP-A-7-322798

上述した薬剤加熱蒸散装置50は、蒸散孔55を人の指などが入りにくい程度の大きさとすることで高温部との不用意な接触を防止している一方、これによって蒸散孔55の大きさが必然的に小さくなっていた。このため、薬剤含有体51から上方に蒸散する薬剤の一部がカバー体54の内面と接触して液滴化するという現象が生じ、蒸散効率の低下や、カバー体54の変色・劣化などの問題を有していた。   The above-described chemical heating transpiration apparatus 50 prevents the careless contact with the high temperature part by making the transpiration hole 55 small enough for human fingers or the like to enter. Inevitably became smaller. For this reason, a phenomenon occurs in which a part of the medicine that evaporates upward from the medicine-containing body 51 comes into contact with the inner surface of the cover body 54 to form liquid droplets, resulting in a decrease in evaporation efficiency, discoloration / deterioration of the cover body 54, Had a problem.

そこで、本発明は、蒸散した薬剤の液滴化を抑制して蒸散効率を高めることができる薬剤蒸散装置の提供を目的とする。   Accordingly, an object of the present invention is to provide a chemical transpiration apparatus capable of increasing the transpiration efficiency by suppressing the transpiration of the transpirational drug.

本発明の前記目的は、薬剤を含浸させた担持体を加熱して薬剤を蒸散させる薬剤蒸散装置であって、発熱体を有する装置本体と、前記装置本体に取り付けられた保護カバーと、前記発熱体と前記保護カバーとの間に前記担持体を保持する保持手段を備え、前記保持手段は、使用状態で前記担持体を起立保持すると共に、前記担持体と前記保護カバーとの間に空間部を形成し、前記空間部は、少なくとも上部が外部と連通するように形成される薬剤蒸散装置により達成される。   The object of the present invention is a drug transpiration apparatus for heating a carrier impregnated with a drug to evaporate the drug, the apparatus main body having a heating element, a protective cover attached to the apparatus main body, and the heat generation A holding means for holding the carrier between a body and the protective cover, the holding means standingly holding the carrier in a use state, and a space portion between the carrier and the protective cover The space portion is achieved by a chemical evaporation device formed so that at least the upper portion communicates with the outside.

この薬剤蒸散装置において、前記空間部は、前記担持体と前記保護カバーとの間隔が3mm以上となるように形成されることが好ましい。   In this chemical evaporation apparatus, it is preferable that the space portion is formed so that a distance between the carrier and the protective cover is 3 mm or more.

また、前記保護カバーは、使用状態で前記担持体よりも上方に延出する延出部を有することが可能である。この場合、前記延出部は、前記担持体表面の直上位置を超えない範囲で前記担持体側に向けて張り出すように形成されていることが好ましい。   The protective cover may have an extending portion that extends upward from the carrier when in use. In this case, it is preferable that the extending portion is formed so as to project toward the carrier side within a range not exceeding a position directly above the surface of the carrier.

また、前記保持手段は、前記担持体の裏面全体が前記発熱体の発熱面と接触するように前記担持体を保持することが好ましい。   Moreover, it is preferable that the holding means holds the carrier so that the entire back surface of the carrier is in contact with the heat generation surface of the heat generator.

また、前記装置本体は、前記担持体が保持される面とは反対側の面に電源プラグを有することが好ましい。   Moreover, it is preferable that the said apparatus main body has a power plug in the surface on the opposite side to the surface where the said support body is hold | maintained.

本発明の薬剤蒸散装置によれば、蒸散した薬剤の液滴化を抑制して蒸散効率を高めることができる。   According to the chemical transpiration apparatus of the present invention, it is possible to suppress the formation of droplets of the transpirated chemical and increase the transpiration efficiency.

以下、本発明の実態形態について添付図面を参照して説明する。図1は、本発明の一実施形態に係る薬剤蒸散装置の概略構成を一部断面で示す側面図であり、図2はその平面図である。図1及び図2に示すように、薬剤蒸散装置1は、装置本体10と、装置本体10に取り付けられた保護カバー20とを備えている。   Hereinafter, actual forms of the present invention will be described with reference to the accompanying drawings. FIG. 1 is a side view showing a schematic configuration of a chemical transpiration apparatus according to an embodiment of the present invention in a partial cross section, and FIG. 2 is a plan view thereof. As shown in FIGS. 1 and 2, the chemical evaporation apparatus 1 includes an apparatus main body 10 and a protective cover 20 attached to the apparatus main body 10.

装置本体10は、筐体状に形成され、前面上部の中央を窪ませるようにして段部11が形成されており、段部11には、PTCヒータなどの電熱ヒータからなる面状の発熱体12が設けられている。発熱体12は、発熱面12aが前方側に位置するように背面側が段部11に固定されており、装置本体10の後面に設けられた電源プラグ13を介して通電加熱できるように構成されている。発熱体温度は40〜170℃の間で適宜選定することが可能であり、芳香剤として使用する場合は好ましくは50〜120℃、より好ましくは60〜90℃である。殺虫剤として使用する場合は好ましくは100〜150℃であり、より好ましくは120〜140℃である。   The apparatus main body 10 is formed in a casing shape, and a step portion 11 is formed so as to be depressed in the center of the upper front surface. The step portion 11 has a planar heating element made of an electric heater such as a PTC heater. 12 is provided. The heat generating body 12 is configured such that the back side is fixed to the step portion 11 so that the heat generating surface 12a is located on the front side, and can be heated by energization via the power plug 13 provided on the rear surface of the apparatus body 10. Yes. The heating element temperature can be appropriately selected between 40 and 170 ° C., and when used as a fragrance, it is preferably 50 to 120 ° C., more preferably 60 to 90 ° C. When used as an insecticide, it is preferably 100 to 150 ° C, more preferably 120 to 140 ° C.

段部11における発熱体12の前方には、薬剤を含浸させた平板状の担持体14が着脱自在に取り付けられる装着部15が形成されている。装着部15は、矢示のように担持体14を上方から挿入して段部11の両側面11aに沿って摺動させ、担持体14の下端部を段部11の下面11bに当接させることにより、担持体14を発熱体12の発熱面12aと近接状態で保持する。担持体14が装着部15に保持された状態においては、担持体14の上端が保護カバー20の上端よりも若干低い位置になることが好ましい。担持体14の表面積(発熱体12と対向する裏面側の面積)は、発熱体12の発熱面12aの面積と同程度か、若干小さい程度であることが好ましい。   A mounting portion 15 to which a flat carrier 14 impregnated with a drug is detachably attached is formed in front of the heating element 12 in the step portion 11. The mounting portion 15 inserts the carrier 14 from above as shown by an arrow and slides the carrier 14 along both side surfaces 11a of the step portion 11 so that the lower end portion of the carrier 14 contacts the lower surface 11b of the step portion 11. As a result, the carrier 14 is held in proximity to the heating surface 12a of the heating element 12. In a state where the carrier 14 is held by the mounting portion 15, it is preferable that the upper end of the carrier 14 is slightly lower than the upper end of the protective cover 20. The surface area of the carrier 14 (the area on the back surface facing the heating element 12) is preferably about the same as or slightly smaller than the area of the heating surface 12 a of the heating element 12.

薬剤担持体14としては、無機及び/又は有機粉末を主剤とする粘着体及び/又は焼結体及び/又は打錠体、パルプを主剤とする紙及び/又は不織布、プラスチックを主剤とする不織布及び/又は織物、その他動植物由来物質を主剤とする不織布及び/又は織物、プラスチックを主剤とするフォーム、プラスチック錬り込み体、植物乾燥体、ゲル体、の少なくとも一つから選ぶことができ、殺虫剤、殺菌剤、芳香剤、消臭剤などの液状の各種薬剤に適宜添加剤を含むものを含浸保持する。薬剤担持体14は、2種以上を用いることも可能であり、この場合、それぞれが混在してもよいし、層状にして重ねあわせるなどしてもよい。   Examples of the drug carrier 14 include an adhesive and / or a sintered body and / or a tablet with an inorganic and / or organic powder as a main component, a paper and / or non-woven fabric with a pulp as a main component, a non-woven fabric with a plastic as a main component, and It can be selected from at least one of woven fabrics and other non-woven fabrics and / or woven fabrics mainly composed of animal and plant-derived substances, plastic-based foams, plastic wrought bodies, dried plant bodies, and gel bodies. In addition, liquid various chemicals such as bactericides, fragrances, and deodorants are appropriately impregnated and retained. Two or more kinds of drug carriers 14 can be used. In this case, each may be mixed, or may be layered and overlapped.

各種薬剤は特に限定はされないが、例えば、芳香剤用香料としては、サンダルウッド油、セダーウッド油、パイン油、サイプレス油、安息香油特など、常温(30℃以下)では揮散しにくい沸点220℃以上の成分及び/又はそれら成分を含有する天然及び/又は合成香料が好ましい。これらの香料組成物は常温揮散性が低く、一旦液滴化した薬剤はその後揮散することがなく蓄積するので、従来の蒸散装置を用い続けた場合には、薬剤の液ダレが生じ住居の床材などを侵食する恐れがあるが、本実施形態の薬剤蒸散装置によれば、後述するように、この問題を効果的に解消することができる。また、薬剤担持体に含浸させる薬剤には酸化防止剤、pH調整剤、着色料、界面活性剤、紫外線吸収剤等を適宜添加することができる。   Various chemicals are not particularly limited. For example, as a fragrance for a fragrance, sandalwood oil, cedarwood oil, pine oil, cypress oil, benzoic oil, etc. And / or natural and / or synthetic fragrances containing these components are preferred. These fragrance compositions have low room temperature volatility, and once a drug has been dropped, it accumulates without volatilization thereafter. Although there is a risk of eroding the material and the like, this problem can be effectively solved according to the chemical evaporation apparatus of this embodiment, as will be described later. In addition, an antioxidant, a pH adjuster, a colorant, a surfactant, an ultraviolet absorber, and the like can be appropriately added to the drug impregnated in the drug carrier.

保護カバー20は、平板状の部材からなり、装置本体10の前面と間隔をあけて対向するように装置本体10の下部に回動軸21を介して取り付けられ、矢示方向に回動自在に構成されている。保護カバー20の大きさは、装置本体10の前面と略同じ大きさとされており、装着部15に装着された担持体14に対応する内面側の位置に2つの押圧突起22,22を備えている。押圧突起22,22は、それぞれ保護カバー20を閉じた状態で担持体14の表面と当接し、担持体14の裏面を発熱体12の発熱面12a全体に密着させる。これにより、担持体14は、前面側が装置本体10の前面と略面一となり、保護カバー20との間に空間部Sが形成された状態で保持される。押圧突起22,22の個数は、単一であってもよく、或いは、3つ以上設けてもよい。   The protective cover 20 is made of a flat plate-like member, and is attached to the lower portion of the apparatus main body 10 via a rotation shaft 21 so as to face the front surface of the apparatus main body 10 with a space therebetween, and is rotatable in the direction indicated by the arrow. It is configured. The size of the protective cover 20 is substantially the same as that of the front surface of the apparatus main body 10, and two pressing protrusions 22 and 22 are provided at positions on the inner surface side corresponding to the carrier 14 mounted on the mounting portion 15. Yes. The pressing protrusions 22, 22 are in contact with the surface of the carrier 14 with the protective cover 20 closed, and the back surface of the carrier 14 is brought into close contact with the entire heat generating surface 12 a of the heat generating member 12. As a result, the carrier 14 is held in a state in which the front surface side is substantially flush with the front surface of the apparatus main body 10 and the space S is formed between the carrier 14 and the protective cover 20. The number of the pressing protrusions 22, 22 may be single, or three or more.

次に、上記構成を有する薬剤蒸散装置1の作動を説明する。本実施形態の薬剤蒸散装置1は、装着部15に担持体14を装着して保護カバー20を閉じた後、図3に示すように、家庭やオフィスなどの壁面40に設置されたコンセント41に電源プラグ13を差し込んで、使用することができる。担持体14は、装着部15及び押圧突起22により起立保持され、発熱体12への通電により加熱される。   Next, the operation of the chemical transpiration apparatus 1 having the above configuration will be described. The chemical evaporation apparatus 1 of the present embodiment attaches the carrier 14 to the mounting portion 15 and closes the protective cover 20, and then, as shown in FIG. 3, the outlet 41 installed on the wall surface 40 such as a home or office The power plug 13 can be inserted and used. The carrier 14 is held upright by the mounting portion 15 and the pressing protrusion 22, and is heated by energizing the heating element 12.

本実施形態においては、押圧突起22による担持体14の押圧により、担持体14の裏面全体が発熱体12の発熱面12aと接触するように構成しているので、発熱体12による担持体14の加熱効率を高めて省電力化を図っている。   In the present embodiment, since the entire back surface of the carrier 14 is in contact with the heat generating surface 12a of the heating element 12 by the pressing of the supporting body 14 by the pressing protrusions 22, the carrier 14 is heated by the heating element 12. Power saving is achieved by increasing the heating efficiency.

担持体14が加熱されると、担持体14に含浸された薬剤は、担持体14と保護カバー20との間に形成された空間部Sに蒸散し、加熱された空気と共に上昇して、担持体14と保護カバー20との上部隙間を介して外部に拡散される。このように、本実施形態の薬剤蒸散装置1は、担持体14を起立状態で保持すると共に、担持体14と保護カバー20との間に空間部Sを形成しているので、保護カバー20は、使用者の指などが発熱体12や担持体14などの高温部に接触するのを有効に防止しつつ、薬剤の上昇流との衝突を回避することができる。この結果、保護カバー20の内面における薬剤の液滴化を抑制することができ、蒸散効率の向上や、保護カバー20の変色・劣化の防止を図ることができる。   When the carrier 14 is heated, the drug impregnated in the carrier 14 evaporates into the space S formed between the carrier 14 and the protective cover 20 and rises together with the heated air. It diffuses outside through the upper gap between the body 14 and the protective cover 20. Thus, since the chemical evaporation apparatus 1 of this embodiment holds the carrier 14 in an upright state and forms the space S between the carrier 14 and the protective cover 20, the protective cover 20 is In addition, it is possible to effectively prevent the user's finger or the like from coming into contact with a high temperature part such as the heating element 12 or the carrier 14, and to avoid collision with the upward flow of the medicine. As a result, the formation of droplets of the medicine on the inner surface of the protective cover 20 can be suppressed, and the transpiration efficiency can be improved and discoloration / deterioration of the protective cover 20 can be prevented.

担持体14と保護カバー20との間に形成される空間部Sは、少なくとも上部が外部と連通するように形成されている必要があるが、より好ましくは、担持体14と保護カバー20との上部隙間に薬剤の上昇流と衝突するおそれがある障害物を何ら介在させないように、薬剤蒸散装置1を構成することが好ましい。一方、空間部Sの両側部及び下部は、薬剤の上昇流に伴い外気が空間部Sに導入されるように構成される限り、一部又は全部を閉塞してもよい。空間部Sの両側部及び下部の全体を閉塞した場合、例えば、保護カバー20の下部に多数の小孔を形成することで、空間部Sへ外気を導入することができる。   The space S formed between the carrier 14 and the protective cover 20 needs to be formed so that at least the upper part communicates with the outside. More preferably, the space S is formed between the carrier 14 and the protective cover 20. It is preferable to configure the drug transpiration apparatus 1 so that there is no obstacle that may collide with the upward flow of the drug in the upper gap. On the other hand, both or both sides and the lower portion of the space portion S may be partially or entirely blocked as long as the outside air is introduced into the space portion S with the upward flow of the medicine. When the entire sides and the lower part of the space S are closed, for example, a large number of small holes are formed in the lower part of the protective cover 20, so that outside air can be introduced into the space S.

図3に示す空間部Sにおける担持体14と保護カバー20との間隙幅aは、小さすぎると、担持体14から蒸散した薬剤が上昇流となる前に保護カバー20の内面に衝突して液滴化するおそれがある。後述する実験結果によれば、カバー20内面における薬剤の液滴化を有効に防止するためには、間隙幅aは3mm以上であることが好ましい。一方、間隙幅aが大きくなりすぎると、担持体14と保護カバー20との間に指が入るおそれがあることから、本実施形態の構成においては、間隙幅aは5mm以下であることが好ましい。   If the gap width “a” between the carrier 14 and the protective cover 20 in the space S shown in FIG. 3 is too small, the liquid evaporated from the carrier 14 collides with the inner surface of the protective cover 20 before the liquid evaporates. May cause droplets. According to the experimental results described below, the gap width a is preferably 3 mm or more in order to effectively prevent the liquid droplets of the medicine on the inner surface of the cover 20. On the other hand, if the gap width a is too large, a finger may enter between the carrier 14 and the protective cover 20. Therefore, in the configuration of the present embodiment, the gap width a is preferably 5 mm or less. .

本実施形態の薬剤蒸散装置1は、電源プラグ13が、装置本体10における担持体14が保持される面とは反対側の面に設けられているので、壁面40から離隔した位置に薬剤を蒸散させることができ、薬剤が壁面40に付着して液滴化するのを防止することができる。但し、本実施形態の構成においても、図3に示す使用状態において壁面40から担持体14の前面までの張り出し距離bが小さすぎると、装置本体10の上方へ拡散した薬剤が壁面40で液滴化するおそれがある。後述する実験結果によれば、壁面40における薬剤の液滴化を有効に防止するためには、張り出し距離bを17.5mm以上とすることが好ましい。一方、張り出し距離bが大きくなりすぎると、使用上邪魔になり易いことから、実用的には30mm以下とすることが好ましい。   In the chemical vaporization device 1 of the present embodiment, the power plug 13 is provided on the surface of the device main body 10 opposite to the surface on which the carrier 14 is held, so that the chemical is vaporized at a position separated from the wall surface 40. It is possible to prevent the medicine from adhering to the wall surface 40 and forming droplets. However, even in the configuration of the present embodiment, if the overhang distance b from the wall surface 40 to the front surface of the carrier 14 is too small in the use state shown in FIG. There is a risk of becoming. According to the experimental results described later, it is preferable that the overhang distance b is 17.5 mm or more in order to effectively prevent the liquid droplets on the wall surface 40. On the other hand, if the overhanging distance b is too large, it tends to be a hindrance in use.

以上、本発明の一実施形態について詳述したが、本発明の具体的な態様は上記実施形態に限定されない。例えば、本実施形態においては、壁面40に設置されたコンセント41に電源プラグ13を差し込んで使用する構成とすることで、使用時の省スペース化を図っているが、例えば、装置本体10の下部に支持台などを設けて床面やテーブル等に載置し、装置本体10に装着した電池等から発熱体12の電源をとるように構成することもできる。   As mentioned above, although one Embodiment of this invention was explained in full detail, the specific aspect of this invention is not limited to the said embodiment. For example, in the present embodiment, the power plug 13 is inserted into the outlet 41 installed on the wall surface 40 for use, thereby saving space during use. It is also possible to provide a support base or the like and place it on a floor surface or a table so that the heating element 12 is powered from a battery or the like attached to the apparatus main body 10.

また、本実施形態においては、発熱体12及び担持体14をいずれも平板状に形成しているが、波板状、円盤状、リング状など種々の形状とすることができる。   Moreover, in this embodiment, although the heat generating body 12 and the support body 14 are all formed in a flat plate shape, they can have various shapes such as a corrugated plate shape, a disc shape, and a ring shape.

また、本実施形態においては、担持体14を起立状態で保持するための保持手段を、装着部15及び押圧突起22により構成しているが、担持体14は必ずしも発熱体12に密着させる必要はなく、押圧突起22を設けずに装着部15のみから保持手段を構成することもできる。   Further, in the present embodiment, the holding means for holding the carrier 14 in an upright state is constituted by the mounting portion 15 and the pressing protrusion 22, but the carrier 14 is not necessarily required to be in close contact with the heating element 12. Alternatively, the holding means can be configured only from the mounting portion 15 without providing the pressing protrusion 22.

担持体14を保持する保持手段の具体的な構成は、保持を確実に行うことができる限り種々の変形が可能である。例えば、図4に示すように、装置本体10の前面に設置された発熱体12から前方に延びる保持ロッド101,101を設け、担持体14に形成した挿通孔141,141に保持ロッド101,101を挿通することにより、担持体14を発熱体12の近傍に配置することができる。この場合、保持ロッド101,101をボルトとして、担持体14の前面側からナットを締結することにより、担持体14を発熱体12に密着させることができる。或いは、図5に示すように、発熱体12の下方から前方に張り出すL字状の保持金具102を設け、担持体14の下端部を保持金具102の先端部と発熱体12との間に挟持するように構成することもできる。   The specific configuration of the holding means for holding the carrier 14 can be variously modified as long as the holding can be reliably performed. For example, as shown in FIG. 4, holding rods 101, 101 extending forward from a heating element 12 installed on the front surface of the apparatus main body 10 are provided, and the holding rods 101, 101 are inserted into insertion holes 141, 141 formed in the carrier 14. The support 14 can be disposed in the vicinity of the heating element 12. In this case, the support 14 can be brought into close contact with the heating element 12 by fastening the nut from the front side of the support 14 using the holding rods 101 and 101 as bolts. Alternatively, as shown in FIG. 5, an L-shaped holding metal fitting 102 projecting forward from below the heating element 12 is provided, and the lower end portion of the carrier 14 is placed between the tip of the holding metal fitting 102 and the heating element 12. It can also be configured to be sandwiched.

保持手段の種々のバリエーションにおいて、例えば図4に示すように、発熱体12の発熱面12a上縁と装置本体10の前面上縁との間に非加熱領域Aが形成される場合、この領域の高さcが大きくなりすぎると、蒸散した薬剤がこの非加熱領域Aで液滴化するおそれがある。後述する実験結果によれば、非加熱領域Aにおける薬剤の液滴化を有効に防止するためには、非加熱領域Aの高さcを5mm以下とすることが好ましい。   In various variations of the holding means, for example, as shown in FIG. 4, when a non-heating area A is formed between the upper edge of the heating surface 12 a of the heating element 12 and the upper edge of the front surface of the apparatus main body 10, If the height c becomes too large, the evaporated chemical may be formed into droplets in the non-heated area A. According to the experimental results to be described later, in order to effectively prevent droplets of the medicine in the non-heated area A, the height c of the non-heated area A is preferably 5 mm or less.

また、本実施形態において、担持体14は、使用状態で鉛直方向に延びるように起立保持されるが、本明細書における起立保持とは、必ずしも鉛直方向の保持のみに限定されず、図6に示すように、担持体14が傾斜状態で保持される場合も含む。この場合、鉛直方向に対する担持体14の傾斜角θが大きくなりすぎると、担持体14の上端と保護カバー20との間隔が大きくなり指などが入りやすくなることから、傾斜角θは、0〜10°であることが好ましい。   Further, in the present embodiment, the carrier 14 is held upright so as to extend in the vertical direction in use, but the upright holding in this specification is not necessarily limited to holding in the vertical direction. As shown, the case where the carrier 14 is held in an inclined state is included. In this case, if the inclination angle θ of the carrier 14 with respect to the vertical direction becomes too large, the gap between the upper end of the carrier 14 and the protective cover 20 becomes large and a finger or the like can easily enter. 10 ° is preferable.

保持手段による担持体14の保持位置は発熱体12の近傍であることが好ましいが、発熱体12と保護カバー20との間に担持体14を保持可能である限り、上記以外の構成にすることも可能である。例えば、保護カバー20の内面側(発熱体12との対向面側)に、挟持や吊持などの適宜手段で担持体14を保持し、保護カバー20に支持された担持体14を、装置本体10の発熱体12で加熱するように構成することもできる。   The holding position of the carrier 14 by the holding means is preferably in the vicinity of the heating element 12. However, as long as the carrier 14 can be held between the heating element 12 and the protective cover 20, a configuration other than the above is used. Is also possible. For example, the carrier 14 is held on the inner surface side of the protective cover 20 (on the side facing the heating element 12) by appropriate means such as clamping or hanging, and the carrier 14 supported by the protective cover 20 is attached to the apparatus main body. It can also be configured to heat with ten heating elements 12.

また、図7に示すように、保護カバー20が、担持体14よりも上方に延出する延出部20aを備えた構成として、この延出部20aが担持体14側に向けて張り出すように構成してもよい。この場合、空間部Sの間隙幅を拡げても、担持体14と保護カバー20との間に指などがより入りにくくなるので、空間部Sの十分なスペースの確保が容易になる。但し、延出部20aの先端が担持体14の表面の直上位置(図7の破線で示す位置)を超えて張り出すと、この超えた部分の内面に、蒸散した薬剤が付着して液滴化するおそれがあるので、延出部20aは、担持体14表面の直上位置を超えない範囲で張り出すように構成することが好ましい。延出部20aの張り出しは、本実施形態のように傾斜させてもよく、或いは、先端部を水平方向に折り曲げてもよい。同様に、保護カバー20の両側面にも担持体14側に向けて張り出す延出部を設けてもよい。   Further, as shown in FIG. 7, the protective cover 20 includes an extending portion 20 a that extends upward from the carrier 14, and the extending portion 20 a projects toward the carrier 14 side. You may comprise. In this case, even if the gap width of the space portion S is increased, it becomes more difficult for a finger or the like to enter between the carrier 14 and the protective cover 20, so that it is easy to secure a sufficient space in the space portion S. However, if the tip of the extended portion 20a protrudes beyond the position directly above the surface of the carrier 14 (the position indicated by the broken line in FIG. 7), the vaporized drug adheres to the inner surface of the excess portion and drops. Therefore, it is preferable that the extending portion 20a is configured to project in a range not exceeding the position directly above the surface of the carrier 14. The overhang of the extending portion 20a may be inclined as in the present embodiment, or the tip portion may be bent in the horizontal direction. Similarly, extending portions that protrude toward the carrier 14 may be provided on both side surfaces of the protective cover 20.

また、保護カバー20は、装置本体10に対して取り付け可能であればよく、例えば、本実施形態のように回動自在とする代わりに、装置本体10に着脱自在に取り付けられるように構成されていてもよい。更に、担持体14の起立保持が可能である限り、保護カバー20が装置本体10に固定されていてもよい。   The protective cover 20 only needs to be attachable to the apparatus main body 10. For example, the protective cover 20 is configured to be detachably attached to the apparatus main body 10 instead of being rotatable as in the present embodiment. May be. Further, the protective cover 20 may be fixed to the apparatus main body 10 as long as the carrier 14 can be held upright.

以下、実施例に基づいて本発明を更に詳細に説明する。但し、本発明は、以下の実施例に限定されるものではない。   Hereinafter, the present invention will be described in more detail based on examples. However, the present invention is not limited to the following examples.

(実施例1)
図3に示す構成の薬剤蒸散装置1において、担持体14と保護カバー20との間隙幅aと、保護カバー20内面における薬剤液滴化の有無との関係を調べた。発熱体12の発熱面12aは、面積を20mm×40mmとし、表面温度を約80℃に維持した。また、担持体14は、面積を20mm×40mm、厚みを1mmとし、サンダルウッド精油を0.1g含浸させた。保護カバー20は、ポリプロピレン製で厚みを2mmとした。常温雰囲気下でサンダルウッド精油の蒸散がほぼ終了した後(99%以上蒸散した後)、保護カバー20内面に薬剤の液滴が発生したか否かを調べた。この結果を表1に示す。
Example 1
In the chemical evaporation apparatus 1 having the configuration shown in FIG. 3, the relationship between the gap width a between the carrier 14 and the protective cover 20 and the presence or absence of chemical droplet formation on the inner surface of the protective cover 20 was examined. The heating surface 12a of the heating element 12 had an area of 20 mm × 40 mm and a surface temperature of about 80 ° C. The carrier 14 had an area of 20 mm × 40 mm, a thickness of 1 mm, and was impregnated with 0.1 g of sandalwood essential oil. The protective cover 20 was made of polypropylene and had a thickness of 2 mm. After the transpiration of the sandalwood essential oil was almost completed under a normal temperature atmosphere (after transpiration of 99% or more), it was examined whether or not a drug droplet was generated on the inner surface of the protective cover 20. The results are shown in Table 1.

Figure 2007202510
表1は、保護カバー20の内面に薬剤の液滴が生じた場合を「×」、液滴が生じなかった場合を「○」で表示している。表1から明らかなように、間隙幅aが3mm以上の場合は、薬剤の液滴が生じておらず良好な結果が得られているが、間隙幅aが2mm以下の場合には、薬剤の液滴が生じる結果となった。
Figure 2007202510
In Table 1, “X” indicates a case where a liquid droplet of a medicine is generated on the inner surface of the protective cover 20, and “◯” indicates a case where no liquid droplet is generated. As is apparent from Table 1, when the gap width a is 3 mm or more, no drug droplets are generated and good results are obtained. However, when the gap width a is 2 mm or less, This resulted in the formation of droplets.

同様の試験を、図6に示す担持体14が傾斜状態で保持される薬剤蒸散装置1でも行い(傾斜角θ:10°)、担持体14の下端と保護カバー20との間隙幅と、薬剤の液滴付着との関係を調べたところ、表1と同じ結果となった。

(実施例2)
図3に示す構成の薬剤蒸散装置1の使用状態において、壁面40から担持体14の前面までの張り出し距離bと、壁面40における薬剤液滴化の有無との関係を調べた。壁面40は壁紙によって形成しており、この壁紙の変色の有無も調べた。試験条件は、実施例1と同様とした。この結果を表2に示す。
A similar test is also performed in the chemical evaporation apparatus 1 in which the carrier 14 shown in FIG. 6 is held in an inclined state (inclination angle θ: 10 °), the gap width between the lower end of the carrier 14 and the protective cover 20, the chemical As a result of investigating the relationship with the droplet adhesion, the same results as in Table 1 were obtained.

(Example 2)
In the use state of the chemical evaporation apparatus 1 having the configuration shown in FIG. 3, the relationship between the overhang distance b from the wall surface 40 to the front surface of the carrier 14 and the presence or absence of drug droplet formation on the wall surface 40 was examined. The wall surface 40 is formed of wallpaper, and the presence or absence of discoloration of the wallpaper was also examined. The test conditions were the same as in Example 1. The results are shown in Table 2.

Figure 2007202510
表2は、壁面40に薬剤の液滴が生じた場合、又は、壁紙の変色が生じた場合を「×」、壁面40の液滴や壁紙の変色がいずれも生じなかった場合を「○」で表示している。表2から明らかなように、張り出し距離bが17.5mm以上の場合は、薬剤の液滴及び壁紙の変色のいずれも生じておらず、良好な結果が得られているが、張り出し距離bが15mm以下の場合には、薬剤の液滴及び壁紙の変色が生じる結果となった。
Figure 2007202510
Table 2 shows that “X” indicates a case where a liquid droplet of the drug is generated on the wall surface 40 or a discoloration of the wallpaper, and “◯” indicates a case where neither the liquid droplet of the wall surface 40 nor the discoloration of the wallpaper occurs. Is displayed. As is clear from Table 2, when the overhang distance b is 17.5 mm or more, neither the liquid droplet of the drug nor the discoloration of the wallpaper is generated, and good results are obtained, but the overhang distance b is In the case of 15 mm or less, discoloration of the droplets of the medicine and the wallpaper resulted.

同様の試験を、図6に示す担持体14が傾斜状態で保持される薬剤蒸散装置1でも行い(傾斜角θ:10°)、壁面40から担持体14の前面上端までの張り出し距離と、薬剤の液滴付着及び壁紙の変色との関係を調べたところ、表2と同じ結果となった。   A similar test is also performed in the chemical evaporation apparatus 1 in which the carrier 14 shown in FIG. 6 is held in an inclined state (inclination angle θ: 10 °), the overhang distance from the wall surface 40 to the upper end of the front surface of the carrier 14, and the chemical When the relationship between the droplet adhesion and the discoloration of the wallpaper was examined, the same results as in Table 2 were obtained.

(実施例3)
図4に示す構成の薬剤蒸散装置1において、非加熱領域Aの高さcと、この非加熱領域Aにおける薬剤液滴化の有無との関係を調べた。試験条件は、実施例1と同様とし、非加熱領域Aはポリプロピレンにより形成した。この結果を表3に示す。
(Example 3)
In the chemical evaporation apparatus 1 having the configuration shown in FIG. 4, the relationship between the height c of the non-heated area A and the presence or absence of drug droplet formation in the non-heated area A was examined. The test conditions were the same as in Example 1, and the non-heated area A was formed of polypropylene. The results are shown in Table 3.

Figure 2007202510
表3は、非加熱領域Aに薬剤の液滴が生じた場合を「×」、液滴が生じなかった場合を「○」で表示している。表3から明らかなように、高さcが3mm以下の場合は、薬剤の液滴が生じておらず良好な結果が得られているが、高さcが5mm以上の場合には、薬剤の液滴が生じる結果となった。
Figure 2007202510
In Table 3, “X” indicates a case where a liquid droplet of the medicine is generated in the non-heated area A, and “◯” indicates a case where no liquid droplet is generated. As is apparent from Table 3, when the height c is 3 mm or less, no drug droplets are generated and good results are obtained. However, when the height c is 5 mm or more, This resulted in the formation of droplets.

本発明の一実施形態に係る薬剤蒸散装置の概略構成を一部断面で示す側面図である。It is a side view which shows the schematic structure of the chemical vaporization apparatus which concerns on one Embodiment of this invention in a partial cross section. 図1に示す薬剤蒸散装置の平面図である。It is a top view of the chemical evaporation apparatus shown in FIG. 図1に示す薬剤蒸散装置の使用状態を示す側面図である。It is a side view which shows the use condition of the chemical | medical agent evaporation apparatus shown in FIG. 図1に示す薬剤蒸散装置の変形例を示す要部斜視図である。It is a principal part perspective view which shows the modification of the chemical vaporization apparatus shown in FIG. 図1に示す薬剤蒸散装置の他の変形例を示す要部側面図である。It is a principal part side view which shows the other modification of the chemical transpiration apparatus shown in FIG. 図1に示す薬剤蒸散装置の更に他の変形例を示す側面図である。It is a side view which shows the other modification of the chemical | medical agent evaporation apparatus shown in FIG. 図1に示す薬剤蒸散装置の更に他の変形例を示す側面図である。It is a side view which shows the other modification of the chemical | medical agent evaporation apparatus shown in FIG. 従来の薬剤蒸散装置の断面図である。It is sectional drawing of the conventional chemical transpiration apparatus.

符号の説明Explanation of symbols

1 薬剤蒸散装置
10 装置本体
11 段部
12 発熱体
12a 発熱面
13 電源プラグ
14 担持体
15 装着部
20 保護カバー
20a 延出部
22 押圧突起
S 空間部
DESCRIPTION OF SYMBOLS 1 Chemical evaporation apparatus 10 Apparatus main body 11 Step part 12 Heat generating body 12a Heat generating surface 13 Power plug 14 Carrier 15 Mounting part 20 Protective cover 20a Extension part 22 Pressing protrusion S Space part

Claims (5)

薬剤を含浸させた担持体を加熱して薬剤を蒸散させる薬剤蒸散装置であって、
発熱体を有する装置本体と、
前記装置本体に取り付けられた保護カバーと、
前記発熱体と前記保護カバーとの間に前記担持体を保持する保持手段を備え、
前記保持手段は、使用状態で前記担持体を起立保持すると共に、前記担持体と前記保護カバーとの間に空間部を形成し、
前記空間部は、少なくとも上部が外部と連通するように形成される薬剤蒸散装置。
A chemical evaporation apparatus that heats a carrier impregnated with a chemical to evaporate the chemical,
An apparatus body having a heating element;
A protective cover attached to the apparatus body;
Comprising holding means for holding the carrier between the heating element and the protective cover;
The holding means stands and holds the carrier in use, and forms a space between the carrier and the protective cover,
The space part is a chemical evaporation apparatus formed so that at least the upper part communicates with the outside.
前記空間部は、前記担持体と前記保護カバーとの間隔が3mm以上となるように形成される請求項1に記載の薬剤蒸散装置。 The chemical evaporation apparatus according to claim 1, wherein the space is formed such that a distance between the carrier and the protective cover is 3 mm or more. 前記保護カバーは、使用状態で前記担持体よりも上方に延出する延出部を有しており、
前記延出部は、前記担持体表面の直上位置を超えない範囲で前記担持体側に向けて張り出すように形成されている請求項1又は2に記載の薬剤蒸散装置。
The protective cover has an extending part that extends upward from the carrier in use,
The drug evaporating apparatus according to claim 1 or 2, wherein the extending portion is formed so as to project toward the carrier in a range not exceeding a position directly above the surface of the carrier.
前記保持手段は、前記担持体の裏面全体が前記発熱体の発熱面と接触するように前記担持体を保持する請求項1から3のいずれかに記載の薬剤蒸散装置。 The chemical evaporation apparatus according to any one of claims 1 to 3, wherein the holding unit holds the carrier so that the entire back surface of the carrier is in contact with the heat generating surface of the heat generator. 前記装置本体は、前記担持体が保持される面とは反対側の面に電源プラグを有する請求項1から4のいずれかに記載の薬剤蒸散装置。

The chemical evaporation apparatus according to any one of claims 1 to 4, wherein the device main body has a power plug on a surface opposite to a surface on which the carrier is held.

JP2006027218A 2006-02-03 2006-02-03 Chemical transpiration device Expired - Fee Related JP5473185B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2006027218A JP5473185B2 (en) 2006-02-03 2006-02-03 Chemical transpiration device
PCT/JP2007/051952 WO2007089019A1 (en) 2006-02-03 2007-02-05 Chemical transpiration apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006027218A JP5473185B2 (en) 2006-02-03 2006-02-03 Chemical transpiration device

Publications (2)

Publication Number Publication Date
JP2007202510A true JP2007202510A (en) 2007-08-16
JP5473185B2 JP5473185B2 (en) 2014-04-16

Family

ID=38327576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006027218A Expired - Fee Related JP5473185B2 (en) 2006-02-03 2006-02-03 Chemical transpiration device

Country Status (2)

Country Link
JP (1) JP5473185B2 (en)
WO (1) WO2007089019A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2452557A2 (en) * 2010-11-16 2012-05-16 Budich International GmbH Active agent dispensing device
WO2013154108A1 (en) * 2012-04-10 2013-10-17 日産自動車株式会社 Vehicular insect repellent device
JP2015009755A (en) * 2013-07-02 2015-01-19 日産自動車株式会社 Vehicle insect deterrent device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452467U (en) * 1987-09-29 1989-03-31
JP2002209997A (en) * 2001-01-24 2002-07-30 Kao Corp Heater
JP2004267197A (en) * 2002-08-28 2004-09-30 Earth Chem Corp Ltd Heating evaporator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH023343Y2 (en) * 1985-09-19 1990-01-25

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452467U (en) * 1987-09-29 1989-03-31
JP2002209997A (en) * 2001-01-24 2002-07-30 Kao Corp Heater
JP2004267197A (en) * 2002-08-28 2004-09-30 Earth Chem Corp Ltd Heating evaporator

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2452557A2 (en) * 2010-11-16 2012-05-16 Budich International GmbH Active agent dispensing device
WO2013154108A1 (en) * 2012-04-10 2013-10-17 日産自動車株式会社 Vehicular insect repellent device
JP2015009755A (en) * 2013-07-02 2015-01-19 日産自動車株式会社 Vehicle insect deterrent device

Also Published As

Publication number Publication date
WO2007089019A1 (en) 2007-08-09
JP5473185B2 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
US9278365B2 (en) Volatile material dispenser and method of emitting a volatile material
NL1018660C2 (en) Dual function display device.
US7341698B2 (en) Electrical evaporator including fan and louver structure
TW512065B (en) Night light air freshener
BRPI0709664A2 (en) volatile material dispenser
DE69627864T2 (en) DEVICE FOR DELIVERING A VOLATILE SUBSTANCE
CN105705170B (en) Emanation system and application method
US7597308B1 (en) Constant-rate volatile material dispensing device
BRPI0708087A2 (en) heated volatile dispenser air treatment device
JP5473185B2 (en) Chemical transpiration device
US20050089502A1 (en) Effervescent delivery system
US7597309B1 (en) Constant-rate volatile material dispensing device
JP5894536B2 (en) Heating evaporator
US7206505B2 (en) Volatizer with integrated thermal cutoff
NZ523081A (en) Air freshner dispenser with offset electrical plug to prevent user from plugging in further devices that could come into contact with the vapour
JP5016291B2 (en) Plate body holder
JP4746849B2 (en) Dispersion method and apparatus for chemicals such as fragrances and repellents
JPH07289139A (en) Heat transpiring device and insecticidal method by heat transpiration
JP4126591B2 (en) Fan type insect repellent device
JP3725858B2 (en) Heating evaporator
JP2001204352A (en) Heating and transpiring device for chemical
JPH0223145B2 (en)
JPH0441977B2 (en)
JPH0223146B2 (en)
PT1044607E (en) ELECTRIC HEATING DEVICE FOR THE VAPORIZATION OF DEODORIZING OR INSECTICIDES

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111027

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140204

R150 Certificate of patent or registration of utility model

Ref document number: 5473185

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees